Abstract:AIM:To explore the influence of angiostatin up-regulation on the biologic behavior of gastric cancer cells in vitro and in vivo, and the potential of angiostatin gene therapy in the treatment of human gastric cancer.METHODS:Mouse angiostatin cDNA was subcloned into the eukaryotic expression vector pcDNA3.1(+) and identified by restriction endonucleases digestion and sequencing. The recombinant vector pcDNA3.1(+)-angio was transfected into human gastric cancer cells SGC7901 with liposome and paralleled with the vector control and the mock control. Angiostatin transcription and protein expression were examined by RT-PCR and Western blot in the stable cell lines selected by G418. Cell proliferation and growth in vitro of the three groups were observed respectively under microscope, cell number counting and FACS. The cells overexpressing angiostatin, vector transfected and untreated were respectively implanted subcutaneously into nude mice. After 30 days the size of tumors formed was measured, and microvessel density count (MVD) in the tumor tissues was assessed by immunohistochemistry with the primary anti-vWF antibody.RESULTS:The recombinant vector pcDNA3.1(+)-angio was confirmed with the correct sequence of mouse angiostatin under the promoter CMV. After 30 d of transfection and selection with G418, macroscopic resistant cell clones were formed in the experimental group transfected with pcDNA 3.1(+)-angio and the vector control. But no untreated cells survived in the mock control. Angiostatin mRNA transcription and protein expression were detected in the experimental group. No significant differences were observed among the three groups in cell morphology, cell growth curves and cell cycle phase distributions in vitro. However, in nude mice model, markedly inhibited tumorigenesis and slowed tumor expansion were observed in the experimental group as compared with the controls, which was paralleled with decreased microvessel density in and around tumor tissues (P<0.05).CONCLUSION:Angiostatin does not directly inhibit human gastric cancer cell proliferation and growth in vitro, but exerts its anti-tumor functions through antiangiogenesis in a paracrine way in vivo.

Targeted Inhibition Of Sp1-Mediated Transcription For Antiangiogenic Therapy Of Metastatic Human Gastric Cancer In Orthotopic Nude Mouse Models

Molecular Basis Of The Synergistic Antiangiogenic Activity Of Bevacizumab And Mithramycin A

Selenium-Binding Protein 1 May Decrease Gastric Cellular Proliferation And Migration

Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.

Altered Expression of Transcription Factor Sp1 Critically Impacts the Angiogenic Phenotype of Human Gastric Cancer

Impacts of Bevacizumab on vascular endothelial growth factor and Sp1 expression in gastric cancer xenografts

Identification of SPINT3 as a Metastatic Suppressor in Gastric Cancer Through Induction of TGF-β1 Secretion

[Effect of Anti-Vascular Endothelial Growth Factor Antibody on the Progression of Human Gastric Cancer Orthotopic Xenotransplanted into Nude Mice].

Angiostatin Up-Regulation in Gastric Cancer Cell SGC7901 Inhibits Tumorigenesis in Nude Mice

Suppression Of Survivin Expression Inhibits In Vivo Tumorigenicity And Angiogenesis In Gastric Cancer

Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.

Lentivirus-mediated PLCγ1 Gene Short-Hairpin RNA Suppresses Tumor Growth and Metastasis of Human Gastric Adenocarcinoma.

Expression of the angiotensin Ⅱtypel receptor in human gastric cancer cells and its antagonist inhibitory effect on growth of xenograft with gastric cancer

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockers on Lymphangiogenesis of Gastric Cancer in a Nude Mouse Model

Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo

Molecular basis of therapeutic approaches to gastric cancer.

Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity

Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R in Combination with Anti-Angiogenesis Therapy on A Pancreatic Cancer Patient-Derived Orthotopic Xenograft (pdox) and Cell-Line Mouse Models

Vezt, A Novel Putative Tumor Suppressor, Suppresses The Growth And Tumorigenicity Of Gastric Cancer

Microrna-610: A Novel Regulator Of Gastric Cancer Migration

Alphastatin Downregulates Vascular Endothelial Cells Sphingosine Kinase Activity and Suppresses Tumor Growth in Nude Mice Bearing Human Gastric Cancer Xenografts